Syngenta Crop Protection unveils new insect control technology called Spiropidion.
Syngenta Crop Protection is introducing Spiropidion, a new insect control technology company officials say will help farmers protect their crops against damaging sucking pests in an effective and environmentally sustainable manner.
Sucking pests that include aphids, whiteflies, and scales devastate high-value fruit and vegetables like tomatoes, oranges, and melons, as well as important arable crops like cotton and soybeans. Spiropidion is safe to natural beneficial insects and pollinators, offering farmers a new tool for Integrated Pest Management (IPM) programs, say Syngenta officials.
Spiropidion results from chemistry-driven innovation within a rare class of insecticides that helps crops from the inside, protecting the whole plant body from attack of damaging sucking pests. This helps secure crop quality, yields, and the livelihood of farmers, say Syngenta officials.
“We are excited to offer farmers a new active ingredient that provides more targeted protection against some of the most difficult and damaging sucking pests,” said Jon Parr, Syngenta president of global crop protection in a Syngenta news release. ”The best way I can describe this new innovation is that it’s kind to nature but hard on pests. Spiropidion is another clear example of how we are accelerating investment to deliver plant health innovations that support farmers, across the world, to grow productively and sustainably.”
The first global registration of a formulated product containing Spiropidion was obtained in Guatemala in September 2020, where the product will be marketed under the brand name Elestal Neo. Planned launches of Spiropidion-containing formulations also include Paraguay and Pakistan in 2021, and Brazil in 2023 (pending registrations). In the European Union, regulatory submission is anticipated for 2022-2023. Future launches across a broad range of crops in more than 60 countries across all continents are expected in the next six years, with peak sales estimated above $400 million.